Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1231 (abbreviated as LINC01231) is a long intergenic non-coding RNA (lincRNA) gene located in the human genome. LincRNAs are a subclass of long non-coding RNAs, transcribed from intergenic regions and not translated into protein products. They are generally involved in the regulation of gene expression, chromatin structure, and enhancer activity, and often act in a tissue- or context-specific manner. However, the specific biological roles and molecular functions of LINC01231 itself have not been well characterized in published literature or public functional genomics databases as of the current date. Like many lincRNAs, LINC01231 may contribute to gene regulation via mechanisms such as RNA-mediated chromatin modification or transcriptional enhancement but evidence specific to LINC01231 is lacking.
Not applicable / none known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1231 (LINC01231).